EMP3 and central nervous system cancer: To understand the effect of EMP3 expression level on patient survival, 514 patients with low-grade glioma and 162 patients with GBM were selected from the TCGA database, and patients with LGG and GBM were divided into two groups according to the median expression level of EMP3.